Physician profile
James M Fellows
NPI 1497762892
$2,888.04
in general payments reported to CMS, 2019-2025
21 companies · $304 in 2025
The $304 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $401 · 2020: $302 · 2021: $582 · 2022: $291 · 2023: $383 · 2024: $626 · 2025: $304.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,020 · Education: $293.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,019.50 |
| Education | $292.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $987.06 | 2019-2025 | Xtandi, Myrbetriq |
| Janssen Biotech, INC. | $622.82 | 2019-2025 | Erleada |
| Boston Scientific Corporation | $291.46 | 2019-2025 | General - Therapies, Lithovue |
| Pfizer INC. | $145.33 | 2021-2025 | |
| Axonics, INC. | $117.23 | 2022-2023 | Axonics, Bulkamid |
| Ethicon US, LLC | $95.21 | 2023-2024 | Stratafix, Surgicel Nu-Knit, Surgiflo Hemostatic Matrix |
| Novartis Pharmaceuticals Corporation | $92.96 | 2022-2025 | |
| Tolmar Pharmaceuticals, INC. | $75.45 | 2020-2022 | |
| Urogen Pharma, INC. | $68.82 | 2024-2025 | |
| Procept Biorobotics Corporation | $65.37 | 2024 | Aquabeam System |
| Abbvie INC. | $59.57 | 2022-2025 | |
| Teleflex LLC | $58.68 | 2021-2023 | Urolift |
| Coloplast Corp | $33.99 | 2019-2025 | |
| Neotract INC. | $33.12 | 2019-2020 | |
| 180 Medical, INC. | $28.00 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $26.12 | 2019 | |
| Endo Pharmaceuticals INC. | $22.61 | 2024 | Xiaflex, Aveed |
| Sumitomo Pharma America, INC. | $22.12 | 2023 | Orgovyx |
| Medtronic, INC. | $15.25 | 2023 | Interstim |
| Tolmar, INC. | $14.90 | 2023 | |
| Urovant Sciences INC | $11.97 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Fellows listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.